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Abstract
Background: Surveys of the public in a number of countries have shown poor recognition of mental
disorders and beliefs about treatment that often diverge from those of health professionals. This lack of
mental health literacy can limit the optimal use of treatment services. Australia and Japan are countries
with very different mental health care systems, with Japan emphasising hospital care and Australia more
oriented to community care. Japan is also more collectivist and Australia more individualist in values. These
differences might influence recognition of disorders and beliefs about treatment in the two countries.
Methods: Surveys of the public were carried out in each country using as similar a methodology as
feasible. In both countries, household interviews were carried out concerning beliefs in relation to one of
four case vignettes, describing either depression, depression with suicidal thoughts, early schizophrenia or
chronic schizophrenia. In Australia, the survey involved a national sample of 3998 adults aged 18 years or
over. In Japan, the survey involved 2000 adults aged between 20 and 69 from 25 regional sites spread
across the country.
Results: The Japanese public were found to be more reluctant to use psychiatric labels, particularly for
the depression cases. The Japanese were also more reluctant to discuss mental disorders with others
outside the family. They had a strong belief in counsellors, but not in GPs. They generally believe in the
benefits of treatment, but are not optimistic about full recovery. By contrast, Australians used psychiatric
labels more often, particularly "depression". They were also more positive about the benefits of seeking
professional help, but had a strong preference for lifestyle interventions and tended to be negative about
some psychiatric medications. Australians were positive about both counsellors and GPs. Psychiatric
hospitalization and ECT were seen negatively in both countries.
Conclusion: There are some major differences between Australia and Japan in recognition of disorders
and beliefs about treatment. Some of these may relate to the different health care systems, but the
increasing openness about mental health in Australia is also likely to be an explanatory factor.
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While there is now a range of effective methods for the
treatment and management of various mental disorders,
many people still receive no professional help or do not
receive optimal help [1]. There are many factors that affect
this unmet need for treatment. One of these is a lack of
mental health literacy on the part of the public, specifi-
cally a lack of knowledge of how to recognise mental dis-
orders and beliefs about treatment that are at variance
with those of health professionals [2].
Surveys in several countries have found that many mem-
bers of the public do not correctly recognise disorders in a
case vignette [3-5] and that they misunderstand terms
such as "schizophrenia" and "mania" [6-8]. Failure to use
correct psychiatric labels may cause problems of commu-
nication with health practitioners. For example, it is
known that GPs are more likely to detect a mental disor-
der if the patient presents the symptoms in psychological
rather than somatic terms [9,10], and if the patient explic-
itly raises the possibility of a mental disorder with the GP
[11,12].
Beliefs about various types of professional help are also
important. For example, if a person with a mental disor-
der believes that consulting a psychiatrist or psychologist
is unlikely to be helpful, this will reduce their chance of
getting appropriate help. Surveys in Australia and Ger-
many have found that psychiatrists and psychologists are
rated less highly than GPs for depression, but are more
likely to be seen as helpful for schizophrenia [8,13].
Beliefs about types of treatment also play a role. Surveys
in several countries have found predominantly negative
attitudes towards psychotropic medication [7,13-18],
both because of concern about side effects and the belief
that medications only deal with the symptoms rather than
the causes [15-18]. Such beliefs may affect adherence to
prescribed medication. By contrast, psychological thera-
pies are seen more positively [7,13,16,18-20], as are com-
plementary therapies such as vitamins and herbs [13,20].
While surveys of public beliefs have been carried out in a
number of countries, little is known about cross-cultural
differences in mental health literacy. In the present paper
we report data from surveys in Australia and Japan that
were carried out at the same time using as similar a meth-
odology as possible. The contrast between these two
countries is interesting because of their very different sys-
tems of mental health care. While both countries have a
high level of economic development and a high standard
of health care, Australia places more emphasis on com-
munity care of people with mental disorders and more
attention is paid to the high prevalence disorders such as
depression. By contrast, in Japan there is more emphasis
on hospital care, with much longer in-patient stays than
in Australia, and the mental health system is largely con-
cerned with the lower prevalence psychotic disorders. The
factors leading to the emphasis on hospital care in Japan
include: financial incentives for private hospital in-patient
treatment under the national insurance scheme, a lack of
community support programs, and the strong stigma
against people with mental disorders [21]. Australia also
has a system reliant on general practitioners as the first
point of call for any health problem and as the gatekeep-
ers to specialist care. By contrast, in Japan there is no spe-
cific training in primary care. Family practitioners with
offices in the community provide primary care, but they
are trained in other specialities [21]. Another difference
between the countries, supported by informal observa-
tions, is that psychological treatments are more promi-
nent in Australia than in Japan. There may also be cultural
differences in the acceptability of expressing negative
emotions and displaying behavior that departs from
social norms, with Australian society being more individ-
ualist and Japanese society more collectivist. Given these
differences, we expected some major differences in knowl-
edge and beliefs about mental disorders and their treat-
ment between the two countries.
Methods
Survey interview
Interview questionnaires were developed for each country
to have a common core of questions that would allow
comparisons between countries, and a country-specific
component to allow investigation of issues particular to
each country. The common core was based on the inter-
view used in an earlier Australian survey [2], but with
additional questions. The interview was based on a
vignette of a person with a mental disorder. On a random
basis, respondents were shown one of four vignettes: a
person with major depression, one with major depression
together with suicidal thoughts, a person with early schiz-
ophrenia, and one with chronic schizophrenia. All
vignettes were written to satisfy the diagnostic criteria for
either major depression or schizophrenia according to
DSM-IV and ICD-10. The vignette with depression and the
one with early schizophrenia were written to satisfy at a
minimal level these diagnostic criteria, so that we could
ascertain the public's reaction to cases of developing dis-
order that had reached the point where intervention was
needed. The vignette of the person with depression
together with suicidal thoughts was identical to the
depression vignette in all respects except the suicidal
thoughts and was designed to assess how this symptom
affected the public's response. The chronic schizophrenia
vignette was designed to assess the response to someone
with a severe long-standing disorder, where acceptance
seemed less likely. Respondents were also randomlyPage 2 of 14
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("Mary") versions of the vignette.
The depression vignette (John version) was:
John is 30 years old. He has been feeling unusually sad
and miserable for the last few weeks. Even though he is
tired all the time, he has trouble sleeping nearly every
night. John doesn't feel like eating and has lost weight. He
can't keep his mind on his work and puts off making deci-
sions. Even day-to-day tasks seem too much for him. This
has come to the attention of his boss, who is concerned
about John's lowered productivity.
The depression with suicidal thoughts vignette was:
John is 30 years old. He has been feeling unusually sad
and miserable for the last few weeks. Even though he is
tired all the time, he has trouble sleeping nearly every
night. John doesn't feel like eating and has lost weight. He
can't keep his mind on his work and puts off making any
decisions. Even day-to-day tasks seem too much for him.
This has come to the attention of John's boss who is con-
cerned about his lowered productivity. John feels he will
never be happy again and believes his family would be
better off without him. John has been so desperate, he has
been thinking of ways to end his life.
The early schizophrenia vignette was:
John is 24 and lives at home with his parents. He has had
a few temporary jobs since finishing school but is now
unemployed. Over the last six months he has stopped see-
ing his friends and has begun locking himself in his bed-
room and refusing to eat with the family or to have a bath.
His parents also hear him walking about his bedroom at
night while they are in bed. Even though they know he is
alone, they have heard him shouting and arguing as if
someone else is there. When they try to encourage him to
do more things, he whispers that he won't leave home
because he is being spied upon by the neighbour. They
realize he is not taking drugs because he never sees anyone
or goes anywhere.
The chronic schizophrenia vignette was:
John is 44 years old. He is living in a boarding house in an
industrial area. He has not worked for years. He wears the
same clothes in all weathers and has left his hair to grow
long and untidy. He is always on his own and is often seen
sitting in the park talking to himself. At times he stands
and moves his hands as if to communicate to someone in
nearby trees. He rarely drinks alcohol. He speaks carefully
using uncommon and sometimes made-up words. He is
polite but avoids talking with other people. At times he
accuses shopkeepers of giving information about him to
other people. He has asked his landlord to put extra locks
on his door and to remove the television set from his
room. He says spies are trying to keep him under observa-
tion because he has secret information about interna-
tional computer systems which control people through
television transmitters. His landlord complains that he
will not let him clean the room which is increasingly dirty
and filled with glass objects. John says he is using these "to
receive messages from space".
After being presented with the vignette, respondents were
asked two open-ended questions: "What would you say, if
anything, is wrong with John/Mary?" and "How do you
think John/Mary could best be helped?" Then followed a
series of questions asking the respondent to rate the likely
helpfulness of various interventions (rated as likely to be
helpful, harmful or neither for the person in the vignette).
The interventions were: a typical GP or family doctor; a
typical chemist (pharmacist); a counselor; a social worker;
a telephone counseling service, such as Lifeline; a psychi-
atrist; a psychologist; help from close family; help from
close friends; a naturopath or a herbalist; the clergy, a
minister or priest; John/Mary tried to deal with his/her
problems on his/her own; vitamins and mineral, tonics or
herbal medicines; pain relievers, such as aspirin, codeine
or panadol; antidepressants; antibiotics; sleeping pills;
anti-psychotics; tranquillizers such as valium; becoming
physically more active, such as playing more sport, or
doing a lot more walking or gardening; reading about
people with similar problems and how they have dealt
with them; getting out and about more; attending courses
or relaxation, stress management, meditation or yoga; cut-
ting out alcohol altogether; psychotherapy; hypnosis;
being admitted to a psychiatric ward of a hospital; under-
going electro-convulsive therapy (ECT); having an occa-
sional alcoholic drink to relax; going on a special diet or
avoiding certain foods. Next were questions asking about
the likely result for the person in the vignette with and
without "the sort of professional help you think is most
appropriate" The response options were: Full recovery
with no further problems; Full recovery, but problems
would probably re-occur; Partial recovery; Partial recov-
ery, but problems would probably re-occur; No improve-
ment; Get worse.
The rest of the common core interview is not relevant to
the analyses reported here; it involved questions on
knowledge of causes and risk factors, beliefs associated
with stigma and discrimination, contact with people like
those in the vignette, and the health of the respondent.
The Australian survey
A household survey was carried out of Australian adults
aged 18 or over by the company AC Nielsen. HouseholdsPage 3 of 14
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and territories and metropolitan and rural areas. Up to 5
call backs were made to metropolitan selections and 3 to
non-metropolitan selections. Interviews were sought with
the person in the household who had the most recent
birthday. To achieve a target sample of 4,000 interviews
with adults aged 18 years or over, visits were made to
28,947 households. The outcome of these visits was: no
contact after repeated visits 14,630; vacant house or lot
306; refused 7,815; person sampled within household
temporarily unavailable 1,132; no suitable respondent in
household 287; did not speak English 383; incapable of
responding 213; and unavailable for the duration of the
survey 181. The achieved sample was 3998 persons, with
1001 receiving the depression vignette, 999 the depres-
sion with suicidal thoughts vignette, 997 the early schizo-
phrenia vignette, and 1001 the chronic schizophrenia
vignette.
In addition to the common core component, the Austral-
ian survey interview had questions about awareness of
depression in the media and about Australia's national
depression initiative.
Ethics approval was given by the Human Research Ethics
Committee of the Australian National University.
The Japanese survey
A survey manual supplied from Australia was translated
into Japanese and entrusted to Yamate Information
Processing Center Ltd. for use with the target population
aged 20–69 years, as a rule using the same procedures as
Australia. The survey questionnaire, which was developed
by the Australian researchers (AFJ, HC, KMG), was tenta-
tively translated into Japanese. Then a native English
translator, who had not seen the original English text,
translated the Japanese version back into English. By com-
paring the two English versions, it was possible to confirm
the accuracy of the original translation. There were no sig-
nificant differences between the original text and the
reverse translation. Finally, a Japanese version of the ques-
tionnaire was produced, which involved formatting the
text into Japanese style and making slight wording adjust-
ments. The names of the characters in the vignettes were
translated into the Japanese style, viz. "A-o"(putting an o
sound at the end is often used for a man's name) or "B-ko"
(putting ko at the end is often used for a woman's name),
instead of "John" or "Mary" which were used in the Eng-
lish text.
As well as the questions taken from the Australian survey,
the Japanese survey asked questions concerning such
issues as psychiatric health and welfare policy, the bodies
implementing related services, the existence of action
groups, and the change in the Japanese name for schizo-
phrenia by the Japanese Society of Psychiatry and Neurol-
ogy (i.e. from "split personality disorder" to
"schizophrenia"). These additions were made to clarify
the current Japanese situation and issues in related fields.
Further, an original Japanese manual was also created and
adopted for use concerning points of interest in the imple-
mentation of home visits.
The survey method used was home visit interviews. It was
not feasible to do a national survey of randomly selected
households in Japan because of constraints of human
resources, funding and time. It was therefore decided to
sample a range of areas that differed in whether they were
large or small cities, whether the area had many psychiat-
ric patients or not, and whether the area had a high suicide
rate or not. Using this approach, Japan was divided into 5
areas and 5 research sites were selected in each of these
areas, giving a total of 25 geographic sites. As the survey
was conducted during the winter, and because it was dif-
ficult to ensure that there would be enough survey inter-
viewers, implementation in Hokkaido and Shikoku
prefectures proved troublesome. Additional reasons for
selection of the 25 regional sites were that they were places
of comparatively high population within the relevant
regions, the survey interviewers could use public trans-
port, and the urban areas involved no particular incon-
veniences for the researchers to visit within a certain range
using public transportation. 80 households were selected
from each site, giving a total of 2000. At each site there
were 4 interviewers who took responsibility for 20 house-
holds each. The survey was conducted over the period
from 19 November to 12 December 2003. Each of the
four vignettes was received by 250 people. Half received a
male version of a vignette and half the female version.
At the start of the survey, an explanatory meeting was held
for the survey interviewers in each region. As many mem-
bers of the research team as possible attended these
explanatory meetings. Eighty-five survey interviewers were
recruited for this research with an average age of 50 and an
average of 17 years' experience of interviewing in various
types of surveys. The areas for the survey interviewers to
canvass were allocated on the basis of where they lived.
The question of where the individual survey interviewers
should go was determined mutually among the survey
interviewers themselves, and by the head survey inter-
viewer (supervisor). As a rule, one survey interviewer con-
ducted 20 interviews, but this was considerably flexible,
given the number of years of individual experience and
what the individual survey interviewer could handle. The
interviews were conducted according to the following pro-
cedure: visit the target's home and present the written
greetings and request (a draft had been prepared by cer-
tain survey bodies, which was put into final form after
checks by the research team members), then explain thePage 4 of 14
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for their participation in the research, start the interview
and follow through to completion, check that nothing
had been omitted from the survey responses, and hand
over the remuneration (1000 yen cash voucher). Data
were not collected on the refusal rate for this survey.
Statistical analysis
Data were pooled across male and female versions of each
vignette and percent frequencies calculated. For the Aus-
tralian survey, percentages were calculated applying sur-
vey weights to give better population estimates. Ninety-
five percent CIs were estimated using the Complex Sam-
ples procedure in SPSS 12.0. This procedure takes account
of sampling weights and geographic clustering in the sam-
ple. For the Japanese survey, percentage frequencies and
95% CIs were calculated using unweighted data with SPSS
12.0.
Because of the very different cultures of Australia and
Japan, it is possible that any differences in question
endorsement rates might be due to subtleties of language
or to the social rules applying to the interview situation, as
well as to genuine differences in beliefs about treatment
and outcome. For this reason, we have not relied on sta-
tistical significance of absolute percentages between coun-
tries, but rather on the broad patterns of responses,
particularly where percent endorsement was ordered very
differently across questions.
Results
Recognition of disorders
Table 1 shows the results from both countries. In Aus-
tralia, "depression" was the term used most often to
describe both the depression vignette and the depression
with suicidal thoughts vignette. "Schizophrenia/psycho-
sis" was the term used most often to describe both of the
schizophrenia vignettes, while the generic term "mental
illness" was also commonly used for these vignettes.
In Japan, no single term predominated for describing the
depression vignettes, with "depression", "stress" and "psy-
chological/mental/emotional problems" being the most
common. For the early schizophrenia vignette, the generic
categories of "mental illness" and "psychological/mental/
emotional problems" were used most frequently, while
for the chronic schizophrenia vignette, "schizophrenia"
and "psychological/mental/emotional problems" were
most commonly used.
Best method of help
Table 2 shows the frequency of various responses to the
open-ended question about how the person in the
vignette could best be helped. In Australia, half the
respondents mentioned seeing a GP for the depression
vignettes. Other common responses to the depression
vignettes were seeing a counselor or talking with friends or
family. For the schizophrenia vignettes, seeing a psychia-
trist was commonly mentioned, in addition to seeing a GP
or counselor or talking with friends or family.
In Japan, the most commonly mentioned help for the
depression vignettes was counseling and family or friends.
For the schizophrenia vignettes, seeing a counselor or a
psychiatrist were commonly mentioned, but talking it
over with family or friends was less commonly mentioned
than for the depression vignettes. Seeing a GP was seldom
mentioned for any vignette.
Beliefs about specific interventions
Tables 3, 4, 5 show the data on the ratings of likely help-
fulness of interventions. The Australian public gave simi-
Table 1: Percentage (and 95% CI) of respondents mentioning each category to describe the problem shown in the vignette
Category mentioned Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
Depression Australia 65.3 (60.5–69.8) 77.3 (72.7–81.3) 34.8 (30.5–39.4) 9.6 (7.0–13.0)
Japan 22.6 (18.9–26.3) 35.0 (30.8–39.2) 13.6 (10.6–16.6) 9.6 (7.0–12.2)
Schizophrenia/Psychosis Australia 0.0 (0.0–0.0) 0.5 (0.1–1.6) 41.2 (36.5–46.0) 36.1 (31.5–40.9)
Japan 2.2 (0.9–3.5) 1.2 (0.2–2.2) 17.2 (13.9–20.5) 33.4 (29.3–37.5)
Nervous breakdown Australia 0.7 (0.3–2.1) 1.6 (0.8–3.3) 1.7 (0.9–3.2) 1.0 (0.3–3.4)
Japan 2.0 (0.8–3.2) 2.6 (1.2–4.0) 2.6 (1.2–4.0) 2.4 (1.1–3.7)
Psychological/Mental/Emotional problems Australia 4.5 (2.9–6.8) 6.0 (4.2–8.7) 12.9 (10.1–16.3) 14.3 (10.9–18.5)
Japan 29.4 (25.4–33.4) 24.8 (21.0–28.6) 28.4 (24.4–32.4) 27.2 (23.3–31.1)
Mental illness Australia 3.0 (1.7–5.1) 5.5 (3.7–8.2) 23.0 (19.4–27.0) 35.8 (31.4–40.4)
Japan 9.2 (6.7–11.7) 10.2 (7.5–12.9) 21.6 (18.0–25.2) 12.8 (9.9–15.7)
Stress Australia 16.6 (13.1–20.8) 10.9 (8.3–14.3) 3.1 (1.8–5.3) 2.8 (1.4–5.5)
Japan 25.0 (21.2–28.8) 19.8 (16.3–23.3) 5.0 (3.1–6.9) 3.8 (2.1–5.5)Page 5 of 14
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person in the vignette could best be helped
Type of help mentioned Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
See a doctor/GP Australia 56.3 (52.5–60.0) 49.3 (44.4–54.1) 32.1 (27.6–37.0) 21.0 (17.2–25.4)
Japan 20.8 (17.2–24.4) 20.0 (16.5–23.5) 13.4 (10.4–16.4) 15.8 (12.6–19.0)
See a psychiatrist Australia 13.0 (10.7–15.6) 18.2 (14.9–22.0) 32.0 (27.8–36.4) 27.9 (23.6–32.6)
Japan 43.8 (39.4–48.2) 49.0 (44.6–53.4) 58.6 (54.3–62.9) 60.0 (55.7–64.3)
Take medication Australia 6.1 (4.7–7.8) 8.7 (6.5–11.5) 8.3 (6.0–11.4) 11.7 (9.0–15.1)
Japan 3.4 (1.8–5.0) 8.0 (5.6–10.4) 7.8 (5.4–10.2) 5.8 (3.7–7.9)
See a counselor or have counseling Australia 27.7 (24.7–30.9) 37.4 (33.2–41.8) 28.9 (24.7–33.4) 20.8 (17.3–24.7)
Japan 62.0 (57.7–66.3) 74.8 (71.0–78.6) 76.4 (72.7–80.1) 72.2 (68.3–76.1)
Talk over with friends/family Australia 22.9 (19.8–26.4) 24.0 (20.0–28.6) 21.9 (18.0–26.3) 14.4 (11.2–18.4)
Japan 71.8 (67.8–75.8) 70.4 (66.4–74.4) 43.8 (39.4–48.2) 45.2 (40.8–49.6)
Person must first recognize problem Australia 5.4 (3.8–7.6) 6.6 (4.3–9.9) 5.3 (3.3–8.4) 6.0 (4.1–8.7)
Japan 23.4 (19.7–27.1) 24.4 (20.6–28.2) 23.4 (19.7–27.1) 21.8 (18.2–25.4)
Other Australia 37.9 (34.0–41.8) 36.0 (31.1–41.1) 40.1 (34.9–45.4) 49.8 (44.6–55.0)
Japan 8.4 (6.0–10.8) 2.6 (1.2–4.0) 4.4 (2.6–6.2) 7.2 (4.9–9.5)
Don't know Australia 1.8 (1.1–3.0) 2.5 (1.4–4.6) 2.0 (1.0–3.7) 4.8 (3.1–7.5)
Japan 0.4 (0.0–1.0) 1.0 (0.1–1.9) 1.6 (0.5–2.7) 1.2 (0.2–2.2)
Note: because multiple responses were possible, these percentages do not add up to 100%
Table 3: Percentage (95% CI) of respondents rating each type of person as "helpful" for the person described in the vignette
Person Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
GP Australia 87.3 (84.0–90.0) 84.1 (80.8–87.0) 76.7 (72.8–80.2) 76.3 (72.1–80.0)
Japan 30.4 (26.4–34.4) 26.0 (22.1–29.9) 19.0 (15.5–22.5) 22.8 (19.1–26.5)
Pharmacist Australia 35.4 (31.3–39.6) 33.2 (29.1–37.6) 23.6 (20.0–27.6) 28.1 (24.1–32.5)
Japan 6.8 (4.6–9.0) 6.6 (4.4–8.8) 4.2 (2.4–6.0) 4.2 (2.4–6.0)
Counselor Australia 82.2 (78.6–85.4) 85.5 (82.1–88.3) 85.0 (81.8–87.8) 83.1 (79.5–86.1)
Japan 85.8 (82.7–88.9) 87.6 (84.7–90.5) 87.0 (84.0–90.0) 88.6 (85.8–91.4)
Social worker Australia 62.8 (58.3–67.0) 67.2 (62.8–71.4) 68.4 (64.0–72.5) 79.1 (74.8–82.8)
Japan 73.4 (69.5–77.3) 70.2 (66.2–74.2) 68.4 (64.3–72.5) 75.2 (71.4–79.0)
Phone counseling Australia 63.5 (59.0–67.9) 66.2 (61.8–70.4) 56.6 (52.4–60.7) 47.5 (43.0–52.1)
Japan 42.4 (38.1–46.7) 49.8 (45.4–54.2) 35.6 (31.4–39.8) 29.6 (25.6–33.6)
Psychiatrist Australia 65.0 (60.8–69.0) 71.3 (67.1–75.1) 80.5 (76.5–84.0) 80.2 (76.4–83.5)
Japan 69.4 (65.3–73.5) 72.4 (68.5–76.3) 73.0 (69.1–76.9) 79.0 (75.4–82.6)
Psychologist Australia 66.9 (62.5–71.1) 69.7 (65.2–73.8) 73.6 (69.4–77.4) 74.9 (70.8–78.6)
Japan 56.6 (52.2–61.0) 51.2 (46.8–55.6) 56.2 (51.8–60.6) 65.2 (61.0–69.4)
Close family Australia 67.9 (63.1–72.3) 64.8 (60.1–69.2) 62.7 (58.4–66.8) 61.4 (56.2–66.3)
Japan 85.0 (81.9–88.1) 84.2 (81.0–87.4) 76.8 (73.1–80.5) 80.4 (76.9–83.9)
Close friends Australia 78.2 (74.1–81.7) 77.1 (73.2–80.5) 73.0 (68.9–76.7) 72.0 (67.5–76.1)
Japan 84.8 (81.6–88.0) 83.2 (79.9–86.5) 70.4 (66.4–74.4) 70.2 (66.2–74.2)
Naturopath/herbalist Australia 34.9 (30.8–39.3) 31.8 (27.5–36.5) 23.7 (20.2–27.7) 19.4 (16.3–22.9)
Japan 11.2 (8.4–14.0) 14.8 (11.7–17.9) 8.4 (6.0–10.8) 9.0 (6.5–11.5)
Clergy Australia 45.3 (41.0–49.7) 51.7 (47.3–56.0) 37.2 (33.1–41.4) 42.9 (38.3–47.7)
Japan 13.6 (10.6–16.6) 20.0 (16.5–23.5) 11.6 (8.8–14.4) 16.2 (13.0–19.4)
Deal with it alone Australia 13.1 (10.1–16.8) 9.7 (7.0–13.2) 11.4 (8.4–15.3) 11.8 (8.9–15.6)
Japan 24.4 (20.6–28.2) 20.4 (16.9–23.9) 22.4 (18.7–26.1) 21.4 (17.8–25.0)Page 6 of 14
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interventions most commonly endorsed as likely to be
helpful were seeing a GP, counselor, close friends, physi-
cal activity, reading about the problem, getting out more,
learning relaxation, or getting information from a health
educator. The responses were similar for the schizophre-
nia vignettes, except that GPs were rated somewhat lower
and psychiatrists somewhat higher. Seeing a social worker
was also commonly endorsed for the chronic schizophre-
nia vignette.
In Japan, the most commonly endorsed interventions for
the depression vignettes were seeing a counselor, or help
from friends and family. For the schizophrenia vignettes,
seeing a counselor rated highly again, as did close family.
Psychiatrists and social workers were highly endorsed for
the chronic schizophrenia vignette.
In neither country was there a high level of endorsement
for some standard psychiatric interventions: antidepres-
sants for the depression vignettes, antipsychotics for the
schizophrenia vignettes, admission to a psychiatric ward
for the schizophrenia vignettes, or psychotherapy for the
depression vignettes.
Tables 6, 7, 8 show the data on whether interventions
were rated as likely to be harmful. In Australia, "harmful"
ratings were most common for dealing with the problem
alone, sleeping pills, tranquillizers, ECT and admission to
a psychiatric ward. In Japan, such ratings were most com-
mon for dealing with the problem alone, pain relievers,
admission to a psychiatric ward, ECT and going on a spe-
cial diet.
Beliefs about outcomes
Table 9 gives the data on beliefs about outcomes after
receiving professional help and outcomes without profes-
sional help. In Australia, the most common belief is that
a person receiving professional help would have either
full recovery or full recovery with later relapse. In Japan,
the public most commonly believed in either full recovery
with relapse or partial recovery with relapse.
Where professional help was not received, Australians
were most likely to believe the person would get worse.
This was also the most common response in Japan,
although it was less frequently endorsed than in Australia.
Discussion
Below we discuss the results from each country separately
and then compare the results from the two countries.
Public beliefs in Australia
The Australian public showed a relatively high level of rec-
ognition of depression in the vignettes and this rate was
much improved on a similar Australian survey carried out
in 1995 [13]. Recognition of the schizophrenia vignettes
was not as good, but has also improved since the earlier
survey. There was a generally low use of generic lay terms
such as "stress", "psychological/mental/emotional
problems" and "nervous breakdown". An exception is the
generic term "mental illness" which was used by around a
quarter of respondents for the early schizophrenia
vignette and by around a third for the chronic schizophre-
nia vignette.
When asked about people who could help, the Australian
public showed a high endorsement of GPs and coun-
Table 4: Percentage (95% CI) of respondents rating each type of medication as "helpful" for the person described in the vignette
Medication Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
Vitamins, minerals Australia 50.2 (45.4–55.1) 43.7 (39.2–48.3) 31.3 (27.4–35.5) 33.2 (28.9–37.8)
Japan 20.2 (16.7–23.7) 16.4 (13.1–19.7) 10.6 (7.9–13.3) 12.4 (9.5–15.3)
Pain relievers Australia 14.8 (11.7–18.5) 12.3 (9.6–15.7) 7.3 (5.3–9.9) 10.2 (7.7–13.4)
Japan 4.4 (2.6–6.2) 3.6 (2.0–5.2) 4.2 (2.4–6.0) 4.6 (2.8–6.4)
Antidepressants Australia 46.7 (42.4–51.1) 52.5 (48.1–56.7) 49.9 (45.7–54.2) 42.6 (37.9–47.5)
Japan 34.8 (30.6–39.0) 36.0 (31.8–40.2) 38.6 (34.3–42.9) 39.8 (35.5–44.1)
Antibiotics Australia 10.4 (7.9–13.7) 7.9 (5.7–10.8) 4.0 (2.5–6.2) 6.4 (4.5–9.1)
Japan 6.2 (4.1–8.3) 6.0 (3.9–8.1) 4.8 (2.9–6.7) 8.4 (6.0–10.8)
Sleeping pills Australia 23.9 (20.1–28.1) 21.9 (18.6–25.6) 18.1 (14.7–22.1) 11.6 (8.8–15.1)
Japan 31.6 (27.5–35.7) 26.2 (22.3–30.1) 21.4 (17.8–25.0) 24.8 (21.0–28.6)
Antipsychotics Australia 11.2 (8.4–14.8) 16.5 (13.3–20.3) 33.1 (29.0–37.5) 38.2 (34.0–42.6)
Japan 22.6 (18.9–26.3) 21.8 (18.2–25.4) 30.2 (26.2–34.2) 41.2 (36.9–45.5)
Tranquillizers Australia 13.8 (11.0–17.1) 13.8 (11.0–17.1) 17.2 (14.1–20.8) 15.3 (12.6–18.4)
Japan 38.4 (34.1–42.7) 37.0 (32.8–41.2) 38.4 (34.1–42.7) 45.4 (41.0–49.8)Page 7 of 14
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schizophrenia vignettes, more so than in the earlier Aus-
tralian survey [13]. For medications, only around half
endorsed antidepressants for depression, and around a
third endorsed antipsychotics for schizophrenia. There
were similarly low rates of endorsement of psychotherapy
for depression (around half the population) and
admission to a psychiatric ward for schizophrenia
(around a third). While these endorsement rates are
higher than in the 1995 survey [13], they are still low
given that these are standard treatments endorsed by most
Australian mental health professionals [22,23]. This gap
between public and professional beliefs on medication
may limit willingness to accept some recommended
interventions.
The Australian public sees a range of lifestyle interven-
tions as likely to be helpful, such as increased physical
activity, reading about the problem, getting out and about
more, and relaxation training. Some of these interven-
tions have supporting evidence for the treatment of
depression [24], but not for schizophrenia. In general, the
beliefs of the Australian public about treatment are more
positive towards lifestyle interventions than towards med-
ical or psychological interventions.
Dealing with the problem alone was seen as likely to be
harmful by most Australians, more so than in the earlier
survey [13]. A change in such beliefs may help improve
the comparatively low rate of help-seeking observed in a
1997 survey of the Australian public [25]. There was also
a general belief that seeking professional help would
produce a much better outcome for all disorders por-
trayed in the vignettes, with better outcomes expected for
depression than for schizophrenia.
Public beliefs in Japan
When asked what was wrong with the people portrayed in
the vignettes, the Japanese public recognized that there
was a mental health problem, but tended to use non-psy-
Table 5: Percentage (95% CI) of respondents rating each type of intervention as "helpful" for the person described in the vignette
Intervention Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
Physical activity Australia 92.0 (89.3–94.1) 92.5 (89.9–94.4) 87.4 (84.2–90.1) 79.6 (75.6–83.1)
Japan 69.4 (65.3–73.5) 73.4 (69.5–77.3) 73.4 (69.5–77.3) 70.6 (66.6–74.6)
Read about problem Australia 79.3 (75.3–82.8) 79.8 (75.8–83.3) 79.6 (75.5–83.1) 74.7 (70.6–78.4)
Japan 60.0 (55.7–64.3) 59.4 (55.1–63.7) 57.6 (53.3–61.9) 46.8 (42.4–51.2)
Get out more Australia 87.0 (83.8–89.7) 90.3 (87.4–92.6) 87.1 (83.8–89.8) 76.5 (72.3–80.2)
Japan 67.0 (62.9–71.1) 72.0 (68.1–75.9) 67.2 (63.1–71.3) 61.6 (57.3–65.9)
Learn relaxation Australia 83.6 (80.1–86.7) 85.3 (81.8–88.2) 77.1 (73.3–80.5) 68.7 (64.4–72.8)
Japan 38.2 (33.9–42.5) 41.2 (36.9–45.5) 26.2 (22.3–30.1) 29.4 (25.4–33.4)
Cut out alcohol Australia 56.0 (51.7–60.3) 59.8 (55.3–64.1) 66.1 (61.7–70.2) 53.4 (48.7–58.0)
Japan 10.0 (7.4–12.6) 14.2 (11.1–17.3) 18.6 (15.2–22.0) 17.2 (13.9–20.5)
Psychotherapy Australia 44.1 (39.7–48.5) 50.4 (46.0–54.8) 59.1 (54.5–63.6) 62.3 (57.4–66.8)
Japan 49.0 (44.6–53.4) 48.2 (43.8–52.6) 53.8 (49.4–58.2) 67.0 (62.9–71.1)
Hypnosis Australia 22.4 (18.8–26.5) 23.9 (20.2–28.1) 29.9 (25.9–34.3) 30.9 (26.8–35.2)
Japan 28.0 (24.1–31.9) 28.8 (24.8–32.8) 22.4 (18.7–26.1) 33.2 (29.1–37.3)
Psychiatric ward Australia 16.4 (13.2–20.2) 20.2 (16.7–24.3) 31.9 (27.8–36.4) 37.8 (33.4–42.6)
Japan 13.6 (10.6–16.6) 12.0 (9.1–14.9) 22.0 (18.4–25.6) 30.0 (26.0–34.0)
ECT Australia 5.9 (4.0–8.6) 7.2 (4.9–10.4) 6.4 (4.5–9.1) 6.5 (4.4–9.4)
Japan 2.2 (0.9–3.5) 1.4 (0.4–2.4) 1.4 (0.4–2.4) 1.4 (0.4–2.4)
Occasional drink Australia 44.4 (40.1–48.9) 41.8 (37.1–46.5) 31.1 (26.9–34.7) 27.3 (23.1–31.9)
Japan 31.4 (27.3–35.5) 25.0 (21.2–28.8) 15.2 (12.0–18.4) 20.0 (16.5–23.5)
Special diet Australia 48.3 (43.5–53.1) 45.6 (41.0–50.3) 42.1 (37.9–46.3) 39.3 (35.0–43.9)
Japan 5.6 (3.6–7.6) 6.0 (3.9–8.1) 4.4 (2.6–6.2) 4.4 (2.6–6.2)
Web site Australia 57.9 (53.8–61.9) 55.1 (50.4–59.7) 57.5 (53.0–61.8) 44.1 (39.4–49.0)
Japan 45.6 (41.2–50.0) 45.8 (41.4–50.2) 48.4 (44.0–52.8) 47.0 (42.6–51.4)
Expert via email Australia 53.8 (49.6–58.0) 49.6 (44.9–54.3) 55.4 (51.2–59.5) 44.7 (40.1–49.5)
Japan 54.0 (49.6–58.4) 53.6 (49.2–58.0) 56.8 (52.4–61.2) 56.6 (52.2–61.0)
Book Australia 69.1 (65.3–72.6) 64.7 (60.0–69.1) 70.5 (66.5–74.2) 59.2 (54.3–63.9)
Japan 54.0 (49.6–58.4) 49.8 (45.4–54.2) 57.4 (53.1–61.7) 53.6 (49.2–58.0)
Health educator Australia 86.7 (83.6–89.3) 85.9 (82.3–88.8) 86.2 (83.1–88.8) 83.8 (79.7–87.2)
Japan 55.2 (50.8–59.6) 51.2 (46.8–55.6) 46.6 (42.2–51.0) 50.6 (46.2–55.0)Page 8 of 14
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phrenia" for the early schizophrenia vignette, but this
increased to a third for the chronic schizophrenia vignette.
Previous research with Japanese teachers has also shown a
low rate of using the term "schizophrenia" in relation to a
vignette [26]. This term has very negative connotations in
Japan [27], leading psychiatrists to be reluctant to give a
diagnosis of schizophrenia to their patients [28]. There
have also been proposals to replace the term with a more
socially acceptable one [27].
Table 6: Percentage (95% CI) of respondents rating each type of person as "harmful" for the person described in the vignette
Person Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
GP Australia 0.5 (0.2–1.6) 1.1 (0.5–2.5) 2.5 (1.5–4.3) 2.7 (1.5–4.7)
Japan 9.4 (6.8–12.0) 9.0 (6.5–11.5) 12.6 (9.7–15.5) 12.8 (9.9–15.7)
Pharmacist Australia 8.7 (6.3–12.1) 8.1 (5.7–11.5) 8.6 (6.4–11.4) 8.2 (5.8–11.5)
Japan 23.6 (19.9–27.3) 22.0 (18.4–25.6) 22.4 (18.7–26.1) 23.0 (19.3–26.7)
Counselor Australia 3.1 (1.8–5.3) 2.3 (1.3–3.8) 3.0 (1.8–5.0) 2.4 (1.3–4.4)
Japan 1.0 (0.1–1.9) 1.0 (0.1–1.9) 1.4 (0.4–2.4) 1.6 (0.5–2.7)
Social worker Australia 4.5 (3.0–6.7) 5.5 (3.6–8.2) 4.4 (3.0–6.5) 3.0 (1.8–5.0)
Japan 1.4 (0.4–2.4) 3.0 (1.5–4.5) 4.8 (2.9–6.7) 3.0 (1.5–4.5)
Phone counseling Australia 5.9 (4.1–8.6) 6.3 (4.2–9.2) 7.6 (5.3–10.9) 11.1 (8.4–14.6)
Japan 8.6 (6.1–11.1) 6.6 (4.4–8.8) 11.0 (8.2–13.8) 12.0 (9.1–14.9)
Psychiatrist Australia 7.1 (5.0–10.1) 8.1 (5.9–11.0) 5.2 (3.5–7.7) 4.6 (3.1–6.8)
Japan 5.4 (3.4–7.4) 4.8 (2.9–6.7) 6.0 (3.9–8.1) 2.8 (1.3–4.3)
Psychologist Australia 5.1 (3.3–7.9) 5.2 (3.5–7.7) 3.2 (2.0–5.0) 3.6 (2.3–5.6)
Japan 6.0 (3.9–8.1) 8.0 (5.6–10.4) 6.0 (3.9–8.1) 5.0 (3.1–6.9)
Close family Australia 4.9 (3.3–7.1) 4.1 (2.7–6.1) 5.6 (3.9–8.0) 5.3 (3.7–7.7)
Japan 1.6 (0.5–2.7) 1.6 (0.5–2.7) 4.6 (2.8–6.4) 4.4 (2.6–6.2)
Close friends Australia 2.1 (1.1–3.7) 2.6 (1.5–4.5) 3.0 (1.8–4.8) 3.3 (2.0–5.3)
Japan 1.8 (0.6–3.0) 1.4 (0.4–2.4) 4.0 (2.3–5.7) 4.2 (2.4–6.0)
Naturopath/herbalist Australia 11.1 (8.5–14.5) 13.3 (10.5–16.7) 15.1 (12.1–18.7) 15.0 (11.8–18.9)
Japan 18.8 (15.4–22.2) 17.2 (13.9–20.5) 18.2 (14.8–21.6) 21.4 (17.8–25.0)
Clergy Australia 8.1 (5.8–11.1) 9.3 (7.2–11.9) 11.6 (8.9–15.0) 10.3 (7.7–13.6)
Japan 24.2 (20.4–28.0) 14.6 (11.5–17.7) 26.0 (22.1–29.9) 24.4 (20.6–28.2)
Deal with it alone Australia 64.0 (59.6–68.3) 74.8 (70.4–78.7) 70.4 (65.9–74.5) 67.7 (62.9–72.2)
Japan 41.4 (37.1–45.7) 42.6 (38.3–46.9) 38.8 (34.5–43.1) 40.8 (36.5–45.1)
Table 7: Percentage (95% CI) of respondents rating each type of medication as "harmful" for the person described in the vignette
Medication Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
Vitamins, minerals Australia 4.4 (2.9–6.7) 5.4 (3.7–7.9) 5.8 (4.1–8.4) 6.4 (4.5–9.0)
Japan 14.6 (11.5–17.7) 13.8 (10.8–16.8) 14.6 (11.5–17.7) 14.8 (11.7–17.9)
Pain relievers Australia 37.7 (33.0–42.6) 37.3 (33.1–41.7) 38.9 (34.6–43.4) 34.5 (30.0–39.3)
Japan 43.4 (39.0–47.8) 42.6 (38.3–46.9) 36.6 (32.4–40.8) 35.6 (31.4–39.8)
Antidepressants Australia 27.5 (23.5–31.8) 23.4 (19.8–27.4) 22.6 (19.2–26.5) 29.3 (25.2–33.8)
Japan 18.2 (14.8–21.6) 21.2 (17.6–24.8) 15.2 (12.0–18.4) 10.6 (7.9–13.3)
Antibiotics Australia 38.3 (33.4–43.4) 37.8 (33.0–42.8) 35.9 (31.5–40.4) 36.9 (32.4–41.7)
Japan 29.8 (25.8–33.8) 37.6 (33.3–41.9) 29.0 (25.0–33.0) 22.8 (19.1–26.5)
Sleeping pills Australia 49.6 (44.9–54.3) 50.3 (45.9–54.7) 53.1 (48.2–57.9) 58.8 (54.3–63.1)
Japan 27.0 (23.1–30.9) 27.8 (23.9–31.7) 30.0 (26.0–34.0) 27.0 (23.1–30.9)
Antipsychotics Australia 48.3 (43.5–53.1) 40.4 (35.9–45.0) 24.5 (20.6–28.8) 24.5 (20.9–28.5)
Japan 19.0 (15.5–22.5) 23.8 (20.1–27.5) 17.4 (14.1–20.7) 8.4 (6.0–10.8)
Tranquillizers Australia 60.4 (55.8–64.8) 60.1 (55.5–64.5) 47.5 (42.9–52.2) 55.7 (50.9–60.4)
Japan 15.8 (12.6–19.0) 17.6 (14.3–20.9) 13.4 (10.4–16.4) 9.4 (6.8–12.0)Page 9 of 14
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most frequently endorsed counselors, close family and
friends. The belief in the helpfulness of counselors has
been reported previously in a study of Japanese teachers
[26]. Psychiatrists and social workers also received a high
level of endorsement for the chronic schizophrenia
vignette. Dealing with the problem alone was seen to be
harmful by more people than helpful, but still around a
fifth of the population saw it as helpful. Previous research
has shown that there is considerable stigma on seeking
help in Japan and a strong desire for confidentiality,
leading some people to seek services far away from their
place of residence and to pay cash rather than use health
insurance (which would lead to their possible identifica-
tion) [29]. More people saw psychiatric drugs such as anti-
depressants and antipsychotics as helpful than harmful,
but endorsement of these treatments was not high, con-
sistent with results in other developed countries. Admis-
sion to a psychiatric ward was in general not viewed
favorably, but was more accepted for chronic schizophre-
nia. This finding is interesting given the high rate of psy-
chiatric hospitalization in Japan compared to other
countries. Dietary changes were also seen very negatively;
the reason for this is not clear.
When asked about outcomes, the Japanese public was
most likely to believe in partial recovery if the person
received professional help, but that the person would get
worse if there was no help. There is therefore a general
belief that professional help would be beneficial, with
better outcomes expected for depression than for
schizophrenia.
Comparison of Australia and Japan
When asked what was wrong with the people portrayed in
the vignettes, the Australian public was generally more
likely than the Japanese public to use the term "depres-
sion" and less likely to use non-psychiatric terms. How-
ever, for the schizophrenia vignettes, Australians used the
term "schizophrenia" more often for the early schizophre-
Table 8: Percentage (95% CI) of respondents rating each type of intervention as "harmful" for the person described in the vignette
Intervention Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
Physical activity Australia 0.8 (0.2–2.3) 0.3 (0.1–2.2) 0.4 (0.1–1.3) 0.6 (0.2–1.6)
Japan 3.6 (2.0–5.2) 4.0 (2.3–5.7) 3.8 (2.1–5.5) 3.6 (2.0–5.2)
Read about problem Australia 4.1 (2.7–6.2) 5.2 (3.6–7.5) 4.6 (3.1–6.8) 3.6 (2.4–5.4)
Japan 7.6 (5.3–9.9) 7.8 (5.4–10.2) 8.0 (5.6–10.4) 10.4 (7.7–13.1)
Get out more Australia 0.4 (0.1–1.7) 0.3 (0.1–1.5) 1.7 (0.9–3.2) 2.2 (1.2–4.1)
Japan 3.0 (1.5–4.5) 4.8 (2.9–6.7) 7.4 (5.1–9.7) 4.6 (2.8–6.4)
Learn relaxation Australia 1.5 (0.7–3.2) 0.8 (0.3–2.0) 1.0 (0.5–2.3) 3.6 (2.0–6.1)
Japan 7.6 (5.3–9.9) 8.2 (5.8–10.6) 16.4 (13.1–19.7) 13.6 (10.6–16.6)
Cut out alcohol Australia 4.7 (3.1–7.0) 5.3 (3.4–8.0) 3.1 (1.9–5.1) 2.7 (1.6–4.7)
Japan 17.2 (13.9–20.5) 15.0 (11.9–18.1) 11.4 (8.6–14.2) 12.2 (9.3–15.1)
Psychotherapy Australia 10.0 (7.5–13.1) 10.6 (8.0–13.9) 5.7 (3.9–8.2) 7.2 (5.2–10.0)
Japan 7.4 (5.1–9.7) 4.2 (2.4–6.0) 5.2 (3.2–7.2) 2.6 (1.2–4.0)
Hypnosis Australia 17.0 (13.9–20.7) 20.4 (16.5–24.9) 12.8 (10.1–16.2) 16.7 (13.4–20.5)
Japan 14.2 (11.1–17.3) 14.0 (10.9–17.1) 17.4 (14.1–20.7) 10.4 (7.7–13.1)
Psychiatric ward Australia 53.3 (48.4–58.1) 49.2 (44.4–54.1) 38.9 (34.4–43.5) 33.2 (28.9–37.7)
Japan 43.0 (38.6–47.4) 43.6 (39.2–48.0) 38.0 (33.7–42.3) 24.6 (20.8–28.4)
ECT Australia 69.4 (64.4–74.0) 65.9 (61.1–70.5) 63.4 (58.5–68.0) 65.4 (60.5–69.9)
Japan 50.2 (45.8–54.6) 54.4 (50.0–58.8) 50.6 (46.2–55.0) 44.0 (39.6–48.4)
Occasional drink Australia 15.4 (12.6–18.7) 19.1 (15.6–23.2) 29.8 (25.9–34.1) 25.2 (21.3–29.7)
Japan 17.4 (14.1–20.7) 20.2 (16.7–23.7) 31.4 (27.3–35.5) 26.8 (22.9–30.7)
Special diet Australia 7.7 (5.7–10.3) 9.2 (6.9–12.2) 7.7 (5.6–10.6) 7.1 (5.0–9.9)
Japan 55.2 (50.8–59.6) 55.6 (51.2–60.0) 53.2 (48.8–57.6) 50.4 (46.0–54.8)
Web site Australia 14.8 (12.0–18.0) 15.3 (12.3–18.8) 12.7 (10.3–15.6) 19.3 (16.2–22.8)
Japan 8.0 (5.6–10.4) 6.2 (4.1–8.3) 7.2 (4.9–9.5) 9.6 (7.0–12.2)
Expert via email Australia 14.3 (11.6–17.4) 16.4 (13.1–20.3) 13.8 (11.3–16.8) 17.3 (14.2–20.8)
Japan 5.0 (3.1–6.9) 5.6 (3.6–7.6) 5.2 (3.2–7.2) 5.8 (3.7–7.9)
Book Australia 7.7 (5.8–10.1) 9.0 (6.9–11.6) 7.1 (5.1–9.7) 9.4 (7.0–12.4)
Japan 3.0 (1.5–4.5) 4.4 (2.6–6.2) 4.2 (2.4–6.0) 5.0 (3.1–6.9)
Health educator Australia 1.4 (0.7–2.8) 2.0 (1.1–3.5) 1.4 (0.7–2.8) 1.6 (0.8–3.2)
Japan 4.4 (2.6–6.2) 3.8 (2.1–5.5) 5.2 (3.2–7.2) 4.6 (2.8–6.4)Page 10 of 14
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anese applied it more to the chronic vignette. The
Japanese public may be reserving psychiatric labels only
for the more severe cases of mental disorder.
When asked about sources of help, the most striking dif-
ference between the two countries was in attitudes to GPs,
who were seen by the Australians as likely to be helpful
much more often than by the Japanese. This difference
may be related to the nature of the health systems in the
two countries. In Australia, GPs are seen as the first point
of contact for any health problem and the gateway to
other services. There have been efforts in Australia to
improve the training of GPs in mental health and to
encourage the public to seek help from GPs for mental
disorders. In Japan, the role of the GP is an extremely
important issue as well, but their interest in psychiatric
treatment at the moment is not necessarily great, and it is
difficult to say that their ability to diagnose psychiatric
patients correctly is sufficient. Currently, calls are growing
regarding the importance of re-educating GPs in psychiat-
ric medicine, and in future, if this is realized, GPs should
be able to play a suitable role.
Compared to Australians, the Japanese more often
endorse the helpfulness of close family and dealing with
the problem on one's own, perhaps reflecting a cultural
difference in the extent to which mental health issues
should be a private matter or perhaps a lack of knowledge.
Similarly, the Japanese were much less positive about
receiving information from a health educator, but had
similar beliefs to Australians about the helpfulness of
more private information sources, such as books and the
internet.
Australians were much more positive than the Japanese
about lifestyle interventions such as diet, physical activity,
getting out more, relaxation, and cutting out alcohol. The
Table 9: Percentage (95% CI) of respondents giving each outcome as likely for the person described in the vignette
Likely outcome Country Depression 
Vignette
Depression/
Suicidal Vignette
Early 
Schizophrenia 
Vignette
Chronic 
Schizophrenia 
Vignette
With professional help
Full recovery Australia 37.3 (32.8–42.1) 29.6 (25.5–34.1) 24.8 (21.1–29.0) 15.8 (12.4–19.9)
Japan 7.4 (5.1–9.7) 5.8 (3.7–7.9) 4.4 (2.6–6.2) 2.8 (1.3–4.3)
Full recovery with relapse Australia 43.6 (39.2–48.1) 48.2 (43.6–52.8) 47.3 (43.0–51.5) 38.9 (34.3–43.7)
Japan 37.2 (32.9–41.5) 33.8 (29.6–38.0) 34.6 (30.4–38.8) 27.8 (23.9–31.7)
Partial recovery Australia 9.9 (7.6–12.8) 9.0 (6.9–11.7) 12.8 (10.0–16.2) 19.1 (15.9–22.7)
Japan 14.8 (11.7–17.9) 15.4 (12.2–18.6) 13.2 (10.2–16.2) 13.6 (10.6–16.6)
Partial recovery with relapse Australia 5.8 (4.0–8.2) 9.5 (7.1–12.6) 11.9 (9.5–14.9) 21.4 (17.9–25.5)
Japan 37.4 (33.1–41.7) 40.6 (36.3–44.9) 42.2 (37.9–46.5) 52.8 (48.4–57.2)
No improvement Australia 0.1 (0.0–0.8) 0.3 (0.1–1.6) 0.3 (0.0–2.3) 0.8 (0.3–2.0)
Japan 2.4 (1.1–3.7) 1.2 (0.2–2.2) 2.4 (1.1–3.7) 1.6 (0.5–2.7)
Get worse Australia 0.5 (0.1–1.9) 0.2 (0.0–1.3) 0.2 (0.0–2.4) 0.3 (0.1–1.3)
Japan 0.0 (0.0–0.0) 0.2 (0.0–0.6) 0.2 (0.0–0.6) 0.0 (0.0–0.0)
Don't know Australia 2.8 (1.7–4.7) 3.1 (1.9–4.9) 2.8 (1.5–4.9) 3.6 (2.3–5.7)
Japan 0.8 (0.0–1.6) 3.0 (1.5–4.5) 3.0 (1.5–4.5) 1.4 (0.4–2.4)
Without professional help
Full recovery Australia 0.6 (0.2–1.9) 0.4 (0.1–1.7) 0.6 (0.2–1.6) 0.1 (0.0–1.2)
Japan 0.6 (0.0–1.3) 0.8 (0.0–1.6) 0.0 (0.0–0.0) 0.4 (0.0–1.0)
Full recovery with relapse Australia 2.2 (1.2–4.2) 1.5 (0.8–2.8) 0.7 (0.2–2.3) 0.5 (0.1–1.7)
Japan 4.2 (2.4–6.0) 2.6 (1.2–4.0) 2.6 (1.2–4.0) 1.2 (0.2–2.2)
Partial recovery Australia 2.8 (1.6–4.8) 2.5 (1.4–4.6) 0.9 (0.4–2.1) 1.2 (0.5–2.7)
Japan 3.8 (2.1–5.5) 3.8 (2.1–5.5) 2.6 (1.2–4.0) 1.2 (0.2–2.2)
Partial recovery with relapse Australia 9.9 (7.4–13.0) 6.7 (4.7–9.3) 3.7 (2.5–5.6) 1.2 (0.5–3.0)
Japan 12.4 (9.5–15.3) 11.2 (8.4–14.0) 8.6 (6.1–11.1) 4.4 (2.6–6.2)
No improvement Australia 19.3 (16.2–22.9) 14.2 (11.4–17.5) 14.7 (11.7–18.3) 19.4 (15.9–23.4)
Japan 29.8 (25.8–33.8) 26.4 (22.5–30.3) 33.6 (29.4–37.8) 39.4 (35.1–43.7)
Get worse Australia 63.9 (59.4–68.1) 72.0 (67.9–75.9) 78.0 (74.2–81.4) 76.8 (72.2–80.8)
Japan 47.6 (43.2–52.0) 50.8 (46.4–55.2) 49.0 (44.6–53.4) 53.2 (48.8–57.6)
Don't know Australia 1.3 (0.6–2.7) 2.7 (1.4–5.0) 1.3 (0.6–2.9) 0.9 (0.3–2.5)
Japan 1.6 (0.5–2.7) 4.4 (2.6–6.2) 3.6 (2.0–5.2) 0.2 (0.0–0.6)Page 11 of 14
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psychiatric medications as harmful, particularly tranquil-
lizers and sleeping pills.
The Japanese had a lower rate of endorsing clergy as likely
to be helpful, although this was not a highly endorsed
form of help in Australia either. In Australia, it is an
accepted role of the clergy to support members of their
church at times of crisis. In Japan, it has been extremely
rare for a conventional clergyman to play any sort of active
role in the medical field. However, traditional local sha-
mans, and groups that have been viewed as the so-called
"new religions", often offer incantations and prayers for
patients, and in many cases mental illness has been
described as some sort of "curse", which can be "swept
away" by performing suitable rites.
There were also some similarities between the two coun-
tries. Both gave a high rate of endorsement of the helpful-
ness of counselors. In Australia, counselors are not a
registered profession and vary greatly in their training.
They are seen as providing a supportive role – someone
who will listen to problems and give advice. In Japan,
counselors are seen to be associated with "mind care", but
are not a common profession. The term "counseling" is
also used broadly to cover supportive talking relation-
ships that might be provided by people who are not
counselors.
Another similarity between the two countries was the pre-
dominantly negative view of psychiatric wards and ECT.
The negative view of psychiatric wards in both countries is
interesting given the much greater use of this intervention
in Japan than Australia.
When asked about long-term outcomes, the Japanese
were more likely to believe in partial recovery following
treatment, while the Australians were more optimistic
about full recovery. On the other hand, the Australians
were more negative about outcomes without treatment. In
both countries, outcomes for depression were seen more
positively than outcomes for schizophrenia. A factor that
might produce these differences between the two
countries is exposure to people with mental disorders. The
more hospital-based system in Japan might mean that the
public have less contact with people in various stages of
recovery.
Limitations
Both the Australian and Japanese surveys had some meth-
odological limitations. In the Australian survey, the sam-
ple was a national one, but there was a considerable
amount of non-contact and refusal. In the Japanese sur-
vey, the sample was not truly national, but nevertheless
covered the country broadly. The representativeness of the
sample for the country as a whole is unknown, but is
likely to be adequate for investigation of major cross-
national differences. Information on refusal was not
collected.
Another limitation concerns the problems of making
cross-national comparisons between two very different
cultures. Because the interview was designed to suit the
Australian public, it may not have been optimal for the
Japanese. Although we tried to make the survey interviews
as close as possible, there will inevitably be subtleties of
meaning and cultural factors operating within a structured
household survey that could affect the results in unknown
ways. For example, there could be differences in the will-
ingness to use various response categories, the acceptabil-
ity of expressing certain views to an interviewer, or the
comparability of interventions or services that may be
translated as equivalent. To avoid this limitation as far as
possible, we have focused on the broad pattern of
responses between countries, rather than small statisti-
cally significant differences in percent frequencies.
Some of the interventions listed in the interview are not
widely available and respondents would not have had
either direct or indirect experience on which to base their
beliefs. For example, in Australia, receiving information
from a health educator or consulting an expert via email
would be rare interventions. Similarly, in Japan, help
from priests and naturopaths is rare, while telephone
counseling is uncommon but increasing.
The conclusions reached here are limited to the quantita-
tive data collected in community surveys. Future work on
cross-cultural comparisons of mental health literacy
would benefit from associated qualitative research to doc-
ument the cultural differences that underpin any quanti-
tative differences found.
Conclusion
Comparing the two countries, some broad themes are
apparent. The Japanese public could be described as more
reluctant to use psychiatric labels, particularly with milder
disorders, and to be less likely to discuss mental disorders
with others outside the family. They generally believe in
the benefits of treatment, but are not optimistic about full
recovery. By contrast, the Australian public has adopted
psychiatric labels, particularly "depression", more than
the Japanese. They are more positive about the benefits of
seeking professional help, but show a strong preference
for lifestyle interventions and tend to be negative about
some psychiatric medications. Belief in psychological
interventions such as counseling and psychotherapy is
similar in the two countries.Page 12 of 14
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examine differences between the countries in beliefs
about causes of mental disorders and in stigmatizing atti-
tudes. These data will allow us to see whether the greater
reluctance in Japan to label mental disorders and to
expose them outside the family is associated with more
negative attitudes or with stigmatizing causal
explanations.
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